Medtronic

VNUS Medical Acquires Exclusive U.S. Rights to Medtronic's U-Clip Device

Medtronic Found Liable for Antitrust Violations, Ordered to Pay $381.7M in Damages

Medtronic: A Healthier Diagnosis

Medtronic's Fair Value: DCF Analysis Suggests Undervaluation at Current Price

美敦力

Medtronic's 15min chart triggers Bollinger Bands narrowing, KDJ death cross.

Catalyst<ul> <li>Most analysts rate MDT Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Bearish signals are obviously dominant in technical indicators with 2 bearish versus 0 bullish patterns.</li> <li>Fund flow trends show an overall negative direction despite mixed inflow ratios across order sizes.</li></ul>

Key Factors

VNUS Medical Technologies acquired exclusive U.S. distribution rights to Medtronic's (MDT) U-Clip anastomotic device. Medtronic (MDT) was found liable for antitrust violations and ordered to pay $381.7 million in damages to Applied Medical. Medtronic (MDT) closed with a 1.09% gain on February 5, 2026, despite a 21.13% drop in trading volume to $1.02 billion.

MDT News